+1 (646) 663-5829 | +91 702 496 8807

  sales@regionalresearchreports.com

Betalactam and Betalactamase Inhibitors Market Size, Share, and COVID-19 Impact Analysis by Segmentation, Regions, Company Market Share, and Regional Forecast, 2022-2030

Publish Date: Mar 2024
Report ID:HC-1087
Base Year:2023
Report Format:PDF, Excel
Report Pages:193
Region:Global

Table of Content

  1. Global Betalactam and Betalactamase Inhibitors Market Introduction and Market Overview
    1. Objective of the Study
    2. Global Betalactam and Betalactamase Inhibitors Market Scope and Market Estimation
      1. Global Betalactam and Betalactamase Inhibitors Overall Market Size (US$ Mn), Market CAGR (%), Market Forecast (2022-2030)
      2. Global Betalactam and Betalactamase Inhibitors Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2022-2030
    3. Market Segmentation
      1. Drug Type of Global Betalactam and Betalactamase Inhibitors Market
      2. Disease of Global Betalactam and Betalactamase Inhibitors Market
      3. Route of Administration of Global Betalactam and Betalactamase Inhibitors Market
      4. Region of Global Betalactam and Betalactamase Inhibitors Market
  2. Global Betalactam and Betalactamase Inhibitors Market - Executive Summary
    1. Key Findings
      1. Top Impacting Factors
      2. Top Investment Pockets
      3. Market Attractiveness Analysis
    2. Key Companies Introduction
  3. Market Factor Analysis
    1. Global Betalactam and Betalactamase Inhibitors Market Industry Development Trends under COVID-19 Outbreak
      1. Global COVID-19 Status Overview
      2. Influence of COVID-19 Outbreak on Global Betalactam and Betalactamase Inhibitors Market Industry Development
    2. Market Dynamics (Growth Influencers)
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Impact Analysis of Drivers and Restraints
    3. Ecosystem/ Value Chain Analysis
    4. Porter’s Five Forces Analysis
    5. SWOT Analysis
    6. PEST Analysis
    7. Market Opportunity Assessment – by Region (North America/ Europe/ Asia Pacific/ Middle East and Africa/ South America)
      1. By Drug Type
      2. By Disease
      3. By Route of Administration
  4. Global Betalactam and Betalactamase Inhibitors Market: Estimates & Historic Trend Analysis (2017-2020)
  5. Global Betalactam and Betalactamase Inhibitors Market Estimates & Forecast Trend Analysis, by Drug Type
    1. Betalactam and Betalactamase Inhibitors Market Share (%) Estimates and Forecasts, by Drug Type, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Betalactam and Betalactamase Inhibitors Market Revenue (US$ Mn) Estimates and Forecasts, by Drug Type, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Penicillin
    4. Cephalosporin
    5. Carbapenem
    6. Monobactam
    7. Combination
  6. Global Betalactam and Betalactamase Inhibitors Market Estimates & Forecast Trend Analysis, by Disease
    1. Betalactam and Betalactamase Inhibitors Market Share (%) Estimates and Forecasts, by Disease, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Betalactam and Betalactamase Inhibitors Market Revenue (US$ Mn) Estimates and Forecasts, by Disease, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Urinary Tract Infection (excluding cUTI)
    4. Respiratory Infection
    5. Skin Infection
    6. Complicated Urinary Tract Infection (cUTI)
    7. Complicated Intra-Abdominal Infections (cIAI)
    8. Nosocomial Pneumonia
    9. Blood Stream Infection
    10. Other Diseases
  7. Global Betalactam and Betalactamase Inhibitors Market Estimates & Forecast Trend Analysis, by Route of Administration
    1. Betalactam and Betalactamase Inhibitors Market Share (%) Estimates and Forecasts, by Route of Administration, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Betalactam and Betalactamase Inhibitors Market Revenue (US$ Mn) Estimates and Forecasts, by Route of Administration, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Oral
    4. Intravenous
    5. Others
  8. Global Betalactam and Betalactamase Inhibitors Market Analysis and Forecast, by Region
    1. Betalactam and Betalactamase Inhibitors Market Share (%) Estimates and Forecasts, by Region, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Betalactam and Betalactamase Inhibitors Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
      2. North America
      3. Europe
      4. Asia Pacific
      5. Middle East and Africa
      6. South America
  9. North America Betalactam and Betalactamase Inhibitors Market: Estimates & Forecast Trend Analysis
    1. North America Market Assessments & Key Findings
    2. North America Betalactam and Betalactamase Inhibitors Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. North America Betalactam and Betalactamase Inhibitors Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Drug Type
      2. By Disease
      3. By Route of Administration
      4. By Country
        1. U.S.
        2. Canada
        3. Mexico
  10. Europe Betalactam and Betalactamase Inhibitors Market: Estimates & Forecast Trend Analysis
    1. Europe Market Assessments & Key Findings
    2. Europe Betalactam and Betalactamase Inhibitors Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Europe Betalactam and Betalactamase Inhibitors Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Drug Type
      2. By Disease
      3. By Route of Administration
      4. By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Rest of Europe
  11. Asia Pacific Betalactam and Betalactamase Inhibitors Market: Estimates & Forecast Trend Analysis
    1. Asia Pacific Market Assessments & Key Findings
    2. Asia Pacific Betalactam and Betalactamase Inhibitors Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Asia Pacific Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Drug Type
      2. By Disease
      3. By Route of Administration
      4. By Country
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
  12. Middle East & Africa Betalactam and Betalactamase Inhibitors Market: Estimates & Forecast Trend Analysis
    1. Middle East & Africa Market Assessments & Key Findings
    2. Middle East & Africa Betalactam and Betalactamase Inhibitors Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Middle East & Africa Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Drug Type
      2. By Disease
      3. By Route of Administration
      4. By Country
        1. U.A.E.
        2. Saudi Arabia
        3. Egypt
        4. South Africa
        5. Rest of Middle East & Africa
  13. South America Betalactam and Betalactamase Inhibitors Market: Estimates & Forecast Trend Analysis
    1. South America Market Assessments & Key Findings
    2. South America Betalactam and Betalactamase Inhibitors Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. South America Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Drug Type
      2. By Disease
      3. By Route of Administration
      4. By Country
        1. Brazil
        2. Argentina
        3. Colombia
        4. Rest of South America
  14. Manufacturing Cost Structure Analysis
    1. Raw Material and Suppliers
    2. Manufacturing Cost Structure Analysis of Betalactam and Betalactamase Inhibitors
    3. Manufacturing Process Analysis of Betalactam and Betalactamase Inhibitors
    4. Industry Chain Structure of Betalactam and Betalactamase Inhibitors
  15. Marketing, Distributors and Customer
    1. Sales Channel
      1. Direct Channels
      2. Indirect Channels
    2. Betalactam and Betalactamase Inhibitors Distributors
    3. Betalactam and Betalactamase Inhibitors Customer
  16. Competition Landscape
    1. Key Manufacturers Betalactam and Betalactamase Inhibitors Producing Area Distribution, Sales Area, Product Drug Type
    2. Key Manufacturers Betalactam and Betalactamase Inhibitors Product Location Distribution
    3. Market Competition Matrix, by Leading Players
      1. Competition Landscape Analysis
      2. Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    4. List of Emerging, Prominent and Leading Players
    5. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Etc.
  17. Company Profiles
    1. Teva Pharmaceutical Industries Ltd
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    2. Hikma Pharmaceuticals
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    3. Melinta Therapeutics
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    4. Eli Lilly and Company
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    5. Shionogi, Inc
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    6. AstraZeneca plc
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    7. Abbott Laboratories
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    8. Allergan Plc
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    9. F. Hoffmann-La Roche Ltd
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    10. GlaxoSmithKline plc
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    11. Merck & Co. Inc.
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    12. Mylan N.V
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    13. Novartis International AG (Sandoz)
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    14. Pfizer Inc.
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    15. Sanofi
      1. Company Information
      2. Betalactam and Betalactamase Inhibitors Product Offered
      3. Betalactam and Betalactamase Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
  18. Assumptions and Research Methodology
  19. Conclusions and Recommendations
    1. Analysis and Suggestions on New Project Investment
    2. Research Findings and Conclusion

List of Tables

  1. Global Betalactam and Betalactamase Inhibitors Market Historic Analysis (US$ Mn), 2017-2021
  2. Global Betalactam and Betalactamase Inhibitors Market Forecast Opportunity Analysis (US$ Mn), 2022-2030
  3. Global Betalactam and Betalactamase Inhibitors Market Absolute $ Opportunity
  4. Global Betalactam and Betalactamase Inhibitors Market Analysis by Drug Type, 2017-2030
  5. Global Betalactam and Betalactamase Inhibitors Market Analysis by Disease, 2017-2030
  6. Global Betalactam and Betalactamase Inhibitors Market Analysis by Route of Administration, 2017-2030
  7. Global Betalactam and Betalactamase Inhibitors Market Analysis by Region, 2017-2030
  8. North America Betalactam and Betalactamase Inhibitors Market Absolute $ Opportunity
  9. North America Betalactam and Betalactamase Inhibitors Market Analysis by Drug Type, 2017-2030
  10. North America Betalactam and Betalactamase Inhibitors Market Analysis by Disease, 2017-2030
  11. North America Betalactam and Betalactamase Inhibitors Market Analysis by Route of Administration, 2017-2030
  12. North America Betalactam and Betalactamase Inhibitors Market Analysis by Country, 2017-2030
  13. South America Betalactam and Betalactamase Inhibitors Market Absolute $ Opportunity
  14. South America Betalactam and Betalactamase Inhibitors Market Analysis by Drug Type, 2017-2030
  15. South America Betalactam and Betalactamase Inhibitors Market Analysis by Disease, 2017-2030
  16. South America Betalactam and Betalactamase Inhibitors Market Analysis by Route of Administration, 2017-2030
  17. South America Betalactam and Betalactamase Inhibitors Market Analysis by Country, 2017-2030
  18. Europe Betalactam and Betalactamase Inhibitors Market Absolute $ Opportunity
  19. Europe Betalactam and Betalactamase Inhibitors Market Analysis by Drug Type, 2017-2030
  20. Europe Betalactam and Betalactamase Inhibitors Market Analysis by Disease, 2017-2030
  21. Europe Betalactam and Betalactamase Inhibitors Market Analysis by Route of Administration, 2017-2030
  22. Europe Betalactam and Betalactamase Inhibitors Market Analysis by Country, 2017-2030
  23. Asia Pacific Betalactam and Betalactamase Inhibitors Market Absolute $ Opportunity
  24. Asia Pacific Betalactam and Betalactamase Inhibitors Market Analysis by Drug Type, 2017-2030
  25. Asia Pacific Betalactam and Betalactamase Inhibitors Market Analysis by Disease, 2017-2030
  26. Asia Pacific Betalactam and Betalactamase Inhibitors Market Analysis by Route of Administration, 2017-2030
  27. Asia Pacific Betalactam and Betalactamase Inhibitors Market Analysis by Country, 2017-2030
  28. MEA Betalactam and Betalactamase Inhibitors Market Absolute $ Opportunity
  29. MEA Betalactam and Betalactamase Inhibitors Market Analysis by Drug Type, 2017-2030
  30. MEA Betalactam and Betalactamase Inhibitors Market Analysis by Disease, 2017-2030
  31. MEA Betalactam and Betalactamase Inhibitors Market Analysis by Route of Administration, 2017-2030
  32. MEA Betalactam and Betalactamase Inhibitors Market Analysis by Country, 2017-2030

List of Figures

  1. Global Betalactam and Betalactamase Inhibitors Market Historic Y-o-Y Analysis (%), 2017-2021
  2. Global Betalactam and Betalactamase Inhibitors Market Forecast Y-o-Y Analysis (%), 2022-2030
  3. Global Betalactam and Betalactamase Inhibitors Market Share Analysis by Drug Type, 2021 and 2030
  4. Global Betalactam and Betalactamase Inhibitors Market Share Analysis by Disease, 2021 and 2030
  5. Global Betalactam and Betalactamase Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  6. Global Betalactam and Betalactamase Inhibitors Market Share Analysis by Region, 2021 and 2030
  7. North America Betalactam and Betalactamase Inhibitors Market Share Analysis by Drug Type, 2021 and 2030
  8. North America Betalactam and Betalactamase Inhibitors Market Share Analysis by Disease, 2021 and 2030
  9. North America Betalactam and Betalactamase Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  10. North America Betalactam and Betalactamase Inhibitors Market Share Analysis by Country, 2021 and 2030
  11. South America Betalactam and Betalactamase Inhibitors Market Share Analysis by Drug Type, 2021 and 2030
  12. South America Betalactam and Betalactamase Inhibitors Market Share Analysis by Disease, 2021 and 2030
  13. South America Betalactam and Betalactamase Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  14. South America Betalactam and Betalactamase Inhibitors Market Share Analysis by Country, 2021 and 2030
  15. Europe Betalactam and Betalactamase Inhibitors Market Share Analysis by Drug Type, 2021 and 2030
  16. Europe Betalactam and Betalactamase Inhibitors Market Share Analysis by Disease, 2021 and 2030
  17. Europe Betalactam and Betalactamase Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  18. Europe Betalactam and Betalactamase Inhibitors Market Share Analysis by Country, 2021 and 2030
  19. Asia Pacific Betalactam and Betalactamase Inhibitors Market Share Analysis by Drug Type, 2021 and 2030
  20. Asia Pacific Betalactam and Betalactamase Inhibitors Market Share Analysis by Disease, 2021 and 2030
  21. Asia Pacific Betalactam and Betalactamase Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  22. Asia Pacific Betalactam and Betalactamase Inhibitors Market Share Analysis by Country, 2021 and 2030
  23. MEA Betalactam and Betalactamase Inhibitors Market Share Analysis by Drug Type, 2021 and 2030
  24. MEA Betalactam and Betalactamase Inhibitors Market Share Analysis by Disease, 2021 and 2030
  25. MEA Betalactam and Betalactamase Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  26. MEA Betalactam and Betalactamase Inhibitors Market Share Analysis by Country, 2021 and 2030
    market statsville report image

    Want to Review Complete Market Research Report

    Request Sample
    $3150  $2450 save 23%
    $4950  $3850 save 25%
    $7680  $5100 save 30%
    Buy Chapters or Sections

    Avail customized purchase options to meet your exact research needs:

    • Buy sections of this report
    • Buy country level reports
    • Request for historical data
    • Request discounts available for Start-Ups & Universities

    Budget constrains? Get in touch with us for special pricing
    Request Discount

    Phone: +1 (888) 615 4898

    Email: sales@regionalresearchreports.com

    Chat with Us: Click here to start